Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma

Neuro-Oncology - Tập 18 Số 3 - Trang 401-407 - 2016
Julia Furtner1, Veronika Schöpf2,1,3, Katharina Seystahl4, Émilie Le Rhun5,6,7, Roberta Rudà8, Ulrich Roelcke9, Susanne Koeppen10, Anna S. Berghoff11, Christine Marosi11, Paul M. Clément12, Marina Faedi13, Colin Watts14, Wolfgang Wick15, Riccardo Soffietti8, Michael Weller4, Matthias Preusser11
1Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
2BioTechMed, Graz, Austria
3Department of Psychology, University of Graz, Graz, Austria
4Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland
5) Department of Neuro-oncology, University Hospital, Lille, France; Breast cancer Department,
6Oscar Lambret Center, Lille, France
7PRISM Inserm U1191, Villeneuve d'Ascq, France (
8) Department of Neuro-Oncology , University of Torino , Torino, Italy (
9Department of Neurology and Brain Tumor Center, Cantonal Hospital Aarau, Aarau, Switzerland
10Department of Neurology, University of Essen, Essen, Germany
11Department of Medicine I, Medical University of Vienna, Vienna, Austria
12Department of Oncology, KU Leuven, Leuven, Belgium
13Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
14) Department of Clinical Neurosciences, Division of Neurosurgery, University of Cambridge, Cambridge, England
15) Neurology Clinic and National Center for Tumor Disease, University of Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1007/s11060-009-9938-9

10.1093/neuonc/not237

Louis DN Ohgaki H Wiestler OD WHO Classification of Tumors of th Central Nervous System. 4th ed. Lyon, France: IARC Press; 2007.

10.1007/s11060-011-0741-z

Chamberlain, 2004, Temozolomide for treatment-resistant recurrent meningioma, Neurology, 13, 1210, 10.1212/01.WNL.0000118300.82017.F4

10.1007/s11060-005-9093-x

Chamberlain, 2008, Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas, Cancer, 15, 2146, 10.1002/cncr.23803

10.1080/07357900601062339

10.1093/neuonc/nor044

Grunberg, 1990, Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma, J Neurooncol, 8, 61

10.1007/s11060-012-0886-4

10.1215/15228517-2009-010

10.1007/s11060-009-9948-7

10.1093/neuonc/not330

10.1162/jocn.2007.19.7.1081

10.1212/01.wnl.0000271382.62776.b7

10.1007/s11060-014-1358-9

10.1093/neuonc/nou148

10.1093/annonc/mdq634

Baumgarten, 2013, Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas, Histol Histopathol, 28, 1157

10.5414/NP300488

Mautner, 2010, Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation, Ann Oncol, 21, 2294, 2295

10.1111/apm.12052

10.1111/j.1440-1789.2012.01312.x

10.1227/NEU.0b013e3181fb801b

Thông tin
Thông tin xuất bản

Neuro-Oncology

Tập 18 Số 3

401-407

Thông tin tác giả